Clinical Management of Neuropathic Pain: A Problem-Based, Interactive Module

(Internet CME)

Valid until June 2005

 

Faculty Disclosure

 

The “Faculty Disclosure Policy” of the Accreditation Council on Continuing Medical Education (ACCME) requires that physicians participating in a CME activity disclose to the audience any relationship with a pharmaceutical or equipment company which might pose a potential, apparent, or real conflict of interest with regard to their contribution to the activity, and any discussions of unlabeled or investigational use of any commercial product or device not yet approved in the United States.

 

 

Myra Glajchen, DSW is on the Speaker’s Bureau of Purdue Pharma and Janssen Pharmaceutica.

 

Marc Goloff, MD has declared no conflict of interest.

 

Ronald Kaplan, MD is on the Speaker’s Bureau of Purdue Pharma.

 

Russell K. Portenoy, MD has a financial/professional relationship with the following companies:

 

Research Study Contract:

 

Endo Pharmaceuticals

Pfizer

Glaxo SmithKline

Progenics

Ortho Biotech

Purdue Pharma

 

Compensated Consultant for:

 

Abbott

Ligand Pharmaceuticals

Endo Pharmceuticals

Merck

Forest Laboratories

Ortho McNeil

Janssen Pharmaceutica

 

Grants to Beth Israel Dept. of Pain Medicine and Palliative Care from the following:

 

Cephalon

Ligand Pharmaceuticals

Elan Pharmaceuticals

Pfizer

Endo Pharmceuticals

Purdue Pharma

Janssen Pharmaceutica

 

* Intends to reference unlabeled/unapproved uses of drugs or products